US FDA’s Anti-Misinformation Campaigns Look Safer After Supreme Court Oral Arguments

outside of the US Supreme Court building
The Supreme Court heard oral arguments on 18 March in a case stemming from government actions on COVID-19 misinformation. • Source: Shutterstock (Erik Cox Photography)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet